Murray Korc

Title: Murray Korc: Innovator in Cancer Research

Introduction

Murray Korc is a prominent inventor based in Irvine, CA (US). He has made significant contributions to the field of cancer research, particularly in understanding the role of glypican-1 in human breast and pancreatic cancers. His work has implications for both diagnostics and therapeutics in oncology.

Latest Patents

Murray Korc holds a patent titled "Glypican-1 in human breast cancer." This patent highlights the strong expression of glypican-1 in human breast and pancreatic cancer cells, as well as in adjacent fibroblasts. The research indicates that glypican-1 is minimally expressed in normal pancreatic tissues and chronic pancreatitis. His findings suggest that targeting glypican-1 could be a viable strategy for cancer treatment.

Career Highlights

Korc's career is marked by his dedication to cancer research. He has focused on the mechanisms by which glypican-1 influences cancer cell behavior. His studies demonstrate that treatment with phosphoinositide-specific phospholipase-C (PI-PLC) can inhibit the mitogenic responses of pancreatic and breast cancer cells to growth factors. This research opens new avenues for therapeutic interventions in glypican-responsive carcinomas.

Collaborations

Murray Korc has collaborated with notable researchers, including Arthur D. Lander. Their joint efforts have contributed to advancing the understanding of glypican-1's role in cancer biology.

Conclusion

Murray Korc's innovative work in cancer research, particularly regarding glypican-1, showcases his commitment to improving cancer diagnostics and treatment. His contributions are vital in the ongoing battle against cancer, and his patent reflects the potential for future therapeutic developments.